“It is commonly held that the limited market of Personalised Medicine (PM) undermines the relevance of patent protection, given the limited returns on investment.
“It is commonly held that the limited market of Personalised Medicine (PM) undermines the relevance of patent protection, given the limited returns on investment.
Pharmaceutical product development is a multidisciplinary activity involving extensive efforts in systematic product development and optimization in compliance with regulatory authorities to ensure the quality, efficacy and safety of resulting products.
In the late 1950s and early 1960s the drug Thalidomide (marketed in the UK by Distillers Company without sufficient testing) was a sedative and medication prescribed for morning sickness.
In the late 1950s and early 1960s the drug Thalidomide (marketed in the UK by Distillers Company without sufficient testing) was a sedative and medication prescribed for morning sickness.
Whereas the past few years have repeatedly been referred to as the "e;era of biotechnology"e;, most recently the impression has emerged that at least the same degree of attention is being paid to the latest developments in the field of neurosciences.
This blue-chip guide adds quality to the pharmaceutical clinical development process by detailing the need for, and stressing the importance of, an independent audit of clinical data to protect participants and validate study results.
Completely updated to reflect current changes in the law and in practice, Mental Health Law: A Practical Guide is a concise and approachable handbook to mental health law for students and professionals working in psychiatric settings.
This book outlines the role of expert testimony in a trial, including explanations of methods, testing, and science, the legal process, and an overview of the roles of each player.
This book outlines the role of expert testimony in a trial, including explanations of methods, testing, and science, the legal process, and an overview of the roles of each player.
In the last few years, the boom in biobanking has prompted a lively debate on a host of interrelated legal issues, such as the Gordian knot of the ownership of biological materials, as well as privacy concerns.
This comprehensive volume critically examines patient safety in the NHS, discussing both policy initiatives and practical issues with reference to management culture, the legal context and ethical concerns.
This comprehensive volume critically examines patient safety in the NHS, discussing both policy initiatives and practical issues with reference to management culture, the legal context and ethical concerns.
The second edition of a major text provides a thorough exploration of medical law and ethics, written from the perspective of authors who are medical and health care practitioners as well as law lecturers.
Fong and his contributors examine the latest practices and research in end of life (EOL) care, incorporating case examples and recommending strategies for medical-social collaboration and future directions for quality EOL care in Hong Kong.
Fong and his contributors examine the latest practices and research in end of life (EOL) care, incorporating case examples and recommending strategies for medical-social collaboration and future directions for quality EOL care in Hong Kong.
This book examines the effectiveness and limitations of existing body image law, and proposes evidence-based regulatory alternatives informed by public health and psychology research.
A groundbreaking analysis of how the genomic revolution is transforming American society and creating new social divisions-some along racial lines-that promise to fundamentally shape American politics for years to come.
This book examines the effectiveness and limitations of existing body image law, and proposes evidence-based regulatory alternatives informed by public health and psychology research.
This collection brings together key contributions on the ethics of end-of-life decisions, inspired by the publication of What Kind of Death: The Ethics of Determining One's Own Death, a new standard work by professor Govert den Hartogh.
This collection brings together key contributions on the ethics of end-of-life decisions, inspired by the publication of What Kind of Death: The Ethics of Determining One's Own Death, a new standard work by professor Govert den Hartogh.
Die vorliegende Arbeit untersucht unter Rückgriff auf die Rechtsnatur und den Zweck der jeweiligen Dokumentationspflicht haftungs- und beweisrechtliche Rechtsfolgen eines Dokumentationsfehlers.
Dieses Buch widmet sich einer ausführlichen und kritischen Analyse der haftungsrechtlichen Konsequenzen zulassungsüberschreitender Arzneimittelanwendungen am Beispiel von Cytotec in der Geburtshilfe.
Dieses Buch widmet sich einer ausführlichen und kritischen Analyse der haftungsrechtlichen Konsequenzen zulassungsüberschreitender Arzneimittelanwendungen am Beispiel von Cytotec in der Geburtshilfe.
In today's fiercely innovative and complex biopharmaceutical industry, successfully managing a pharmaceutical or biotech company from concept to patients requires exceptional strategic, leadership, and managerial abilities.
In today's fiercely innovative and complex biopharmaceutical industry, successfully managing a pharmaceutical or biotech company from concept to patients requires exceptional strategic, leadership, and managerial abilities.
